Aminoglycoside-resistant Aeromonas hydrophila as part of a polymicrobial infection following a traumatic fall into freshwater

Joshua R. Shak, Jennifer A. Whitaker, Bruce S. Ribner, Eileen M. Burd

Research output: Contribution to journalArticle

16 Scopus citations

Abstract

Amikacin is a first-line treatment for Aeromonas infection due to high efficacy. There are few reports of aminoglycoside-resistant Aeromonas spp. We report a soft tissue infection containing multiple pathogens, including a strain of Aeromonas hydrophila resistant to amikacin, tobramycin, and multiple cephalosporins.

Original languageEnglish (US)
Pages (from-to)1169-1170
Number of pages2
JournalJournal of clinical microbiology
Volume49
Issue number3
DOIs
StatePublished - Mar 1 2011

ASJC Scopus subject areas

  • Microbiology (medical)

Fingerprint Dive into the research topics of 'Aminoglycoside-resistant Aeromonas hydrophila as part of a polymicrobial infection following a traumatic fall into freshwater'. Together they form a unique fingerprint.

  • Cite this